{
  "meta": {
    "title": "00228_Mid_Day_Pyqs_Neet_Pg_-_Final_44",
    "url": "https://brainandscalpel.vercel.app/00228-mid-day-pyqs-neet-pg-final-44-463a9016.html",
    "scrapedAt": "2025-11-29T18:14:27.240Z"
  },
  "questions": [
    {
      "id": 45814,
      "choices": [
        {
          "id": 182883,
          "text": "<p><span style=\"font-size:12.0pt;\">Vitamin A</span></p>"
        },
        {
          "id": 182884,
          "text": "<p><span style=\"font-size:12.0pt;\">Niacin</span></p>"
        },
        {
          "id": 182885,
          "text": "<p><span style=\"font-size:12.0pt;\">Biotin</span></p>"
        },
        {
          "id": 182886,
          "text": "<p>Vitamin B6</p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following deficiency causes xerophthalmia and follicular hyperkeratosis?&nbsp;</span>(FMGE JANUARY 2024)</p>",
      "unique_key": "Q4538953",
      "question_audio": null,
      "question_video": null,
      "map_id": 31148149,
      "difficulty_level": "beginner",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Vitamin A</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Vitamin A deficiency is well known to cause a range of clinical manifestations, primarily affecting the eyes and skin. Key signs and symptoms include:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>Xerophthalmia</strong>: This condition includes dryness of the conjunctiva and cornea, which can progress to keratomalacia and lead to blindness if untreated.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/27/screenshot-2024-05-27-150514.jpg\" alt=\"\" width=\"400\" height=\"272\"></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>Follicular hyperkeratosis</strong>: This is characterized by excessive keratin deposits in hair follicles, leading to rough, bumpy skin.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/27/screenshot-2024-05-27-150535.jpg\" alt=\"\" width=\"300\" height=\"204\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Vitamin A is crucial for maintaining healthy vision, immune function, and skin integrity. Its deficiency can result in:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>Night blindness</strong></span></li><li><span style=\"font-size:12.0pt;\"><strong>Immunosuppression</strong>: Leading to increased susceptibility to infections.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Skin ulceration and corneal ulceration</strong></span></li><li><span style=\"font-size:12.0pt;\"><strong>Atrophy of urinary and respiratory tract epithelium</strong>, increasing the risk of infections in these areas.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Niacin</strong>: Deficiency causes pellagra, characterized by dermatitis, diarrhea, and dementia.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Biotin</strong>: Deficiency can cause dermatitis, alopecia, and neurological symptoms.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Vitamin B6</strong>: Deficiency can cause anemia, dermatitis, and neurological symptoms.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/27/screenshot-2024-05-27-151204.jpg\" alt=\"\" width=\"1000\" height=\"342\"></strong></span></p>",
      "correct_choice_id": 182883,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "FMGE"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 34029,
      "choices": [
        {
          "id": 135951,
          "text": "<p><span style=\"font-size:12.0pt;\">Transfer objects from one hand to another</span></p>"
        },
        {
          "id": 135952,
          "text": "<p><span style=\"font-size:12.0pt;\">Bidextrous approach</span></p>"
        },
        {
          "id": 135953,
          "text": "<p><span style=\"font-size:12.0pt;\">Hand regard</span></p>"
        },
        {
          "id": 135954,
          "text": "<p><span style=\"font-size:12.0pt;\">Hands come in midline</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Identify the milestone shown in the image? (FMGE JAN 2024)</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/29/picture3_LwvitbY.jpg\" alt=\"\" width=\"200\" height=\"239\"></span></p>",
      "unique_key": "Q1232831",
      "question_audio": null,
      "question_video": null,
      "map_id": 31148151,
      "difficulty_level": "beginner",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Transfer objects from one hand to another</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The milestone shown in the image, where the child appears to be manipulating an object, is indicative of the ability to transfer objects from one hand to another. This skill typically develops around 6 months of age and is an important indicator of emerging fine motor skills and hand-eye coordination.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Bidextrous approach:&nbsp;</strong>Refers to the ability to use both hands to pick an object, which typically develops by 4 months. This involves reaching for objects with both hands but does not necessarily involve the transfer of objects between hands.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Hand regard:&nbsp;</strong>This milestone, where an infant looks at and examines their own hand, typically occurs around 3 months of age. The image does not depict this behavior.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Hands come in midline:&nbsp;</strong>By around 4 months, infants begin to bring their hands together in the midline of their body. This is a precursor to more complex hand movements but is not what is shown in the image.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">By around 6 months of age, infants typically develop the ability to transfer objects from one hand to another, demonstrating emerging fine motor skills and hand-eye coordination.</span></p>",
      "correct_choice_id": 135951,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "FMGE",
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 57873,
      "choices": [
        {
          "id": 230853,
          "text": "<p><span style=\"font-size:12.0pt;\">Epiphysis</span></p>"
        },
        {
          "id": 230854,
          "text": "<p><span style=\"font-size:12.0pt;\">Metaphysis</span></p>"
        },
        {
          "id": 230855,
          "text": "<p><span style=\"font-size:12.0pt;\">Diaphysis</span></p>"
        },
        {
          "id": 230856,
          "text": "<p><span style=\"font-size:12.0pt;\">Epiphyseal plate</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:16px;\">Longitudinal growth of a long bone is most likely affected by a fracture involving which of the following regions? (NEET PG 2024)</span></p>",
      "unique_key": "Q5549406",
      "question_audio": null,
      "question_video": null,
      "map_id": 31148163,
      "difficulty_level": "intermediate",
      "subjects_id": [
        3
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans.</strong> <strong>D) Epiphyseal plate</strong></span></p><p><br><span style=\"font-size:12.0pt;\">The epiphyseal plate, also known as the growth plate, is a layer of hyaline cartilage located between the epiphysis (end) and the metaphysis of a long bone. This plate is crucial for the longitudinal growth of bones during childhood and adolescence. Active cell division occurs here, which contributes to the lengthening of the bone. Any damage or fracture at the epiphyseal plate can disrupt this growth process, leading to potential growth abnormalities.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/21/screenshot-2024-09-21-105454.jpg\" alt=\"\" width=\"500\" height=\"428\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/21/screenshot-2024-09-21-105520.jpg\" alt=\"\" width=\"400\" height=\"600\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Epiphysis:</strong> The epiphysis is the rounded end of the long bone but is not directly responsible for bone growth. Fractures here do not significantly impact the longitudinal growth of the bone.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Metaphysis:</strong> The metaphysis is the flared part of the bone between the diaphysis and the epiphyseal plate. Although it plays a role in supporting growth, fractures here do not directly disrupt the longitudinal growth as much as a fracture at the epiphyseal plate would.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Diaphysis:</strong> The diaphysis is the shaft or central part of the long bone. Fractures in the diaphysis typically affect the strength and integrity of the bone but do not interfere with growth lengthwise.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p><br><span style=\"font-size:12.0pt;\">The epiphyseal plate is crucial for the longitudinal growth of bones, and fractures here can significantly impact this process.</span></p>",
      "correct_choice_id": 230856,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/57873/Neet_Pg_Aug_2024_Anatomy_Q_1.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [
        "Factual",
        "RecentNEETPG"
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/57873/Neet_Pg_Aug_2024_Anatomy_Q_1.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 35289,
      "choices": [
        {
          "id": 140967,
          "text": "<p><span style=\"font-size:16px;\">Wide local incision</span></p>"
        },
        {
          "id": 140968,
          "text": "<p><span style=\"font-size:16px;\">Superficial parotidectomy</span></p>"
        },
        {
          "id": 140969,
          "text": "<p><span style=\"font-size:16px;\">Chemotherapy&nbsp;</span></p>"
        },
        {
          "id": 140970,
          "text": "<p><span style=\"font-size:16px;\">Radiation therapy&nbsp;</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:16px;\">What is the preferred treatment for a benign tumor of the superficial parotid gland on FNAC?&nbsp;(FMGE JAN 2024)</span></p>",
      "unique_key": "Q9525146",
      "question_audio": null,
      "question_video": null,
      "map_id": 31148154,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:16px;\"><strong>Ans. B) Superficial parotidectomy</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">The preferred treatment for a benign tumor of the parotid gland, as confirmed by fine-needle aspiration cytology (FNAC), is:</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">This is the treatment of choice for a benign parotid tumors like pleomorphic adenoma. It involves the surgical removal of the entire superficial lobe. Enucleation or simple excision is avoided as the tumor has projections (pseudopodia) which may be left behind leading to recurrence.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option A. Wide local incision:</strong> This is not typically performed for benign parotid tumors. However, now a days it is becoming an alternate to superficial parotidectomy.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option C. Chemotherapy:</strong> This is not a standard treatment for benign parotid tumors as they are typically not responsive to chemotherapy agents.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option D. Radiation therapy:</strong> Radiation therapy is not a standard treatment for benign parotid tumors as it is generally reserved for cancer treatment and not indicated for benign conditions.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Educational Objective:</strong>&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">Superficial parotidectomy is the preferred treatment for a benign tumors like pleomorphic adenoma, providing targeted removal of the entire superficial lobe.</span></p>",
      "correct_choice_id": 140968,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "FMGE",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 56159,
      "choices": [
        {
          "id": 224061,
          "text": "<p><span style=\"font-size:12.0pt;\">Base excision repair</span></p>"
        },
        {
          "id": 224062,
          "text": "<p><span style=\"font-size:12.0pt;\">Double-stranded DNA break repair</span></p>"
        },
        {
          "id": 224063,
          "text": "<p><span style=\"font-size:12.0pt;\">Mismatch repair</span></p>"
        },
        {
          "id": 224064,
          "text": "<p><span style=\"font-size:12.0pt;\">Nucleotide excision repair</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A skin rash gets exaggerated on sun exposure is repaired by which mechanism? (NEET PG 2024)</span></p>",
      "unique_key": "Q9232513",
      "question_audio": null,
      "question_video": null,
      "map_id": 31148167,
      "difficulty_level": "beginner",
      "subjects_id": [
        1
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D) Nucleotide excision repair</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/06/screenshot-2024-09-06-170306.jpeg\" alt=\"\" width=\"1000\" height=\"586\"></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Exposure to ultraviolet (UV) rays from the sun causes damage to DNA by inducing the formation of thymidine dimers, which are covalent linkages between adjacent thymine bases on a DNA strand. These dimers distort the DNA structure, interfering with replication and transcription.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Nucleotide excision repair (NER) is the primary mechanism used by cells to repair this type of damage. The NER pathway identifies the bulky lesions caused by thymidine dimers, excises the damaged section of DNA, and fills in the gap with the correct nucleotides using a DNA polymerase.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">A defect in this repair mechanism can lead to xeroderma pigmentosum, a condition characterized by extreme sensitivity to UV light, leading to severe sunburns, rashes, and a high risk of skin cancer.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Base excision repair:</strong> This mechanism repairs small, non-bulky DNA lesions such as single-base alterations, including deamination and oxidative damage. It does not correct UV-induced thymidine dimers.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Double-stranded DNA break repair:</strong> This repair mechanism is involved in fixing double-strand breaks, which occur due to radiation, replication errors, or certain chemicals. It does not address thymidine dimers.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Mismatch repair:</strong> Mismatch repair corrects errors that occur during DNA replication, such as incorrect base pairing (e.g., A-C instead of A-T). It is not involved in repairing damage from UV light exposure.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Nucleotide excision repair is the primary DNA repair mechanism that corrects damage caused by UV light, such as thymidine dimers.</span></p>",
      "correct_choice_id": 224064,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "Factual",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5919,
      "choices": [
        {
          "id": 23646,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Partial mole</span></span></span></p>"
        },
        {
          "id": 23647,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Choriocarcinoma</span></span></span></p>"
        },
        {
          "id": 23648,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Placental site trophoblastic tumor</span></span></span></p>"
        },
        {
          "id": 23649,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Invasive mole</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:left\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Gestational trophoblastic neoplasm does not include?&nbsp;</span></span>(NEET PG 2019)</p>",
      "unique_key": "Q2288941",
      "question_audio": null,
      "question_video": null,
      "map_id": 31148161,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A) Partial mole </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Gestational trophoblastic disease (GTD) includes a spectrum of conditions characterized by abnormal trophoblastic proliferation. These conditions are broadly classified into molar and non-molar trophoblastic diseases.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hydatidiform Mole:</span></strong></span></span>\r\n\r\n\t<ul style=\"list-style-type:circle\">\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Complete Mole</span></strong></span></span></li>\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Partial Mole</span></strong></span></span></li>\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Invasive Mole</span></strong></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Non-Molar Trophoblastic Diseases:</span></strong></span></span>\r\n\t<ul style=\"list-style-type:circle\">\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Choriocarcinoma</span></strong></span></span></li>\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Placental Site Trophoblastic Tumor</span></strong></span></span></li>\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Epithelioid Trophoblastic Tumor</span></strong></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Gestational Trophoblastic Neoplasia (GTN)</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">, on the other hand, includes only the malignant forms of trophoblastic disease:</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ol>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Invasive Mole</span></strong></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Choriocarcinoma</span></strong></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Placental Site Trophoblastic Tumor</span></strong></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Epithelioid Trophoblastic Tumor</span></strong></span></span></li>\r\n</ol>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A <strong>partial mole</strong> is a type of hydatidiform mole and is considered benign. It is not included under GTN as it does not have malignant potential unless it transforms into an invasive mole, which is rare.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Choriocarcinoma</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: This is a malignant form of GTD and is classified under GTN.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Placental Site Trophoblastic Tumor</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: This is another malignant form of GTD and is included under GTN.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Invasive Mole</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: An invasive mole is a malignant transformation of a hydatidiform mole and is included under GTN.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Partial moles are not classified as gestational trophoblastic neoplasia (GTN) because they are generally benign and non-malignant.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref: Page no 615, Williams Obstetrics 26<sup>th</sup> edition</span></strong></span></span></p>",
      "correct_choice_id": 23646,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "OlderNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 14020,
      "choices": [
        {
          "id": 56041,
          "text": "<p><span style=\"font-size:12.0pt;\">Focal laser photocoagulation</span></p>"
        },
        {
          "id": 56042,
          "text": "<p><span style=\"font-size:12.0pt;\">Pan-retinal photocoagulation</span></p>"
        },
        {
          "id": 56043,
          "text": "<p><span style=\"font-size:12.0pt;\">Grid laser photocoagulation</span></p>"
        },
        {
          "id": 56044,
          "text": "<p><span style=\"font-size:12.0pt;\">Scleral buckling</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">A diabetic patient presented to you with visual acuity of 6/9 in one eye. Further investigations revealed pre-retinal hemorrhages with neovascularization at the optic disc. What is the next step in management?&nbsp;</span>(NEET PG 2022)</p>",
      "unique_key": "Q9883281",
      "question_audio": null,
      "question_video": null,
      "map_id": 31148150,
      "difficulty_level": "beginner",
      "subjects_id": [
        8
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B. Pan-retinal photocoagulation</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The clinical vignette is suggestive of proliferative diabetic retinopathy with high-risk characteristics and the next step in management is pan-retinal photocoagulation.</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>Indications for PRP are:</strong></span></li></ul><ol><li><span style=\"font-size:12.0pt;\">Proliferative Diabetic Retinopathy with high-risk characteristics</span></li><li><span style=\"font-size:12.0pt;\">Neovascularization of iris (NVI)</span></li><li><span style=\"font-size:12.0pt;\">Severe NPDR associated with:</span><ul><li><span style=\"font-size:12.0pt;\">Poor compliance for follow up</span></li><li><span style=\"font-size:12.0pt;\">Before cataract surgery/YAG capsulotomy</span></li><li><span style=\"font-size:12.0pt;\">Renal failure</span></li><li><span style=\"font-size:12.0pt;\">One-eyed patient</span></li><li><span style=\"font-size:12.0pt;\">Pregnancy</span></li></ul></li></ol><ul><li><span style=\"font-size:12.0pt;\">It is done using Yellow – Green spectrum laser - double frequency Nd YAG (532) laser or argon or diode laser.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/05/03/untitled-167.jpg\" alt=\"\" width=\"300\" height=\"215\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Diabetic retinopathy is used to describe retinal changes seen in diabetic patients. It is classified into the following types:</span></p><ul><li><span style=\"font-size:12.0pt;\">Non-proliferative diabetic retinopathy (NPDR)</span></li><li><span style=\"font-size:12.0pt;\">Proliferative diabetic retinopathy (PDR)</span></li><li><span style=\"font-size:12.0pt;\">Diabetic maculopathy</span></li><li><span style=\"font-size:12.0pt;\">Advanced diabetic eye disease</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/09/abbreviated-early-treatment-diabetic-retinopathy-study_page_1.jpg\" alt=\"\" width=\"1000\" height=\"1342\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Focal laser photocoagulation:&nbsp;</strong>Focal laser photocoagulation is used to treat specific areas of retinal edema, particularly in cases of diabetic maculopathy. It is not the first choice for treating PDR with high-risk characteristics.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Grid laser photocoagulation:&nbsp;</strong>Grid laser photocoagulation is also used to treat diffuse macular edema by applying laser burns in a grid pattern. It is not indicated for the treatment of PDR with neovascularization.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Scleral buckling:&nbsp;</strong>Scleral buckling is a surgical procedure used to repair retinal detachment. It is not appropriate for treating PDR with neovascularization and pre-retinal hemorrhages.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Pan-retinal photocoagulation (PRP) is the recommended management for proliferative diabetic retinopathy with high-risk characteristics such as neovascularization at the optic disc and pre-retinal hemorrhages.</span></p>",
      "correct_choice_id": 56042,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "RecentNEETPG",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 84117,
      "choices": [
        {
          "id": 335048,
          "text": "<p><span style=\"font-size:12.0pt;\">Terson’s Syndrome</span></p>"
        },
        {
          "id": 335049,
          "text": "<p><span style=\"font-size:12.0pt;\">Duane’s Syndrome</span></p>"
        },
        {
          "id": 335050,
          "text": "<p><span style=\"font-size:12.0pt;\">Brown’s Syndrome</span></p>"
        },
        {
          "id": 335051,
          "text": "<p><span style=\"font-size:12.0pt;\">Tolosa Hunt Syndrome</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">What is the name for the association of intraocular hemorrhage with subarachnoid hemorrhage? (NEET PG 2017)</span></p>",
      "unique_key": "Q2835319",
      "question_audio": null,
      "question_video": null,
      "map_id": 31148144,
      "difficulty_level": "intermediate",
      "subjects_id": [
        8
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Terson’s Syndrome</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Terson syndrome refers to the combination of bilateral intraocular hemorrhages (including intraretinal, subhyaloid, and vitreous hemorrhage) associated with subarachnoid hemorrhage due to aneurysmal rupture. This condition represents a significant ophthalmological manifestation of intracranial bleeding events.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Options B. Duane's Syndrome:</strong> This is a congenital eye movement disorder characterized by limited abduction, adduction, or both, with narrowing of the palpebral fissure and retraction of the globe on adduction. It has no relation to hemorrhage.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Options C. Brown's Syndrome:&nbsp;</strong>This is a restriction of elevation of the eye in adduction due to a problem with the superior oblique tendon sheath complex. It is not related to hemorrhagic conditions.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Options D. Tolosa Hunt Syndrome:&nbsp;</strong>This is a painful ophthalmoplegia caused by nonspecific inflammation of the cavernous sinus or superior orbital fissure. It is not associated with intraocular or subarachnoid hemorrhage.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong>&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Terson syndrome represents a critical ocular manifestation of subarachnoid hemorrhage, specifically featuring intraocular hemorrhages in association with aneurysmal rupture, which serves as an important diagnostic sign of intracranial bleeding</span></p>",
      "correct_choice_id": 335048,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "OlderNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 84350,
      "choices": [
        {
          "id": 335972,
          "text": "<p>Pagophagia</p>"
        },
        {
          "id": 335973,
          "text": "<p>Koilonychia</p>"
        },
        {
          "id": 335974,
          "text": "<p>Blue Sclera</p>"
        },
        {
          "id": 335975,
          "text": "<p>Macroglossia</p>"
        }
      ],
      "text": "<p>Which of the following signs and symptoms is not highly specific for iron deficiency?&nbsp;(NEET PG 2015)</p>",
      "unique_key": "Q1336065",
      "question_audio": null,
      "question_video": null,
      "map_id": 31148165,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><strong>Correct Answer: D. Macroglossia</strong></p><p>&nbsp;</p><p><strong>Explanation:</strong></p><p>&nbsp;</p><p>Macroglossia (abnormally enlarged tongue) is not a specific finding in iron deficiency anemia. It occurs instead in conditions like amyloidosis, hypothyroidism, and certain genetic disorders such as Down syndrome.</p><p>&nbsp;</p><p><strong>Other Options:</strong></p><p>&nbsp;</p><p><strong>Option A. Pagophagia (ice eating):&nbsp;</strong>This specific form of pica is highly characteristic of iron deficiency. The craving and consumption of ice is a well-recognized manifestation that strongly suggests iron deficiency when present.</p><p>&nbsp;</p><p><strong>Option B. Koilonychia (\"spoon nails\"):</strong> These thin, concave nails with raised edges develop gradually in chronic iron deficiency anemia and serve as a helpful diagnostic sign when present.</p><p>&nbsp;</p><p><strong>Option C. Blue Sclera:&nbsp;</strong>The bluish discoloration of the sclera occurs in advanced iron deficiency due to thinning of collagen, which allows the underlying choroidal veins to become visible. This finding strongly points to significant iron deficiency.</p><p>&nbsp;</p><p><strong>Educational Objective:</strong></p><p>&nbsp;</p><p>Pagophagia, koilonychia, and blue sclera are recognized clinical manifestations of iron deficiency anemia, while macroglossia is not part of this clinical picture and suggests alternative diagnoses.</p>",
      "correct_choice_id": 335975,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "OlderNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 47981,
      "choices": [
        {
          "id": 191519,
          "text": "<p><span style=\"font-size:12.0pt;\">Short Stature</span></p>"
        },
        {
          "id": 191520,
          "text": "<p><span style=\"font-size:12.0pt;\">Webbed Neck</span></p>"
        },
        {
          "id": 191521,
          "text": "<p><span style=\"font-size:12.0pt;\">Low Posterior Hairline</span></p>"
        },
        {
          "id": 191522,
          "text": "<p><span style=\"font-size:12.0pt;\">Abnormal Karyotype</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:16px;\">Which of the following is not true about Noonan Syndrome? (NEET PG 2017)</span></p>",
      "unique_key": "Q8702436",
      "question_audio": null,
      "question_video": null,
      "map_id": 31148160,
      "difficulty_level": "intermediate",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans.&nbsp;D) Abnormal Karyotype</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Noonan Syndrome has a normal karyotype, which makes option D incorrect. This syndrome is characterized by multiple congenital abnormalities but does not involve chromosomal abnormalities that would be visible on a standard karyotype analysis. Noonan Syndrome is actually a genetic disorder caused by mutations in various genes in the RAS-MAPK pathway, but these mutations are at the gene level rather than visible chromosomal abnormalities.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Short Stature</strong>: Correct statement. Short stature is a common clinical feature of Noonan Syndrome. Affected individuals typically have growth issues and remain shorter than average.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Webbed Neck</strong>: Correct statement. Webbed neck (pterygium colli) is a distinctive physical characteristic of Noonan Syndrome. This feature involves excess skin on the neck creating a webbed appearance similar to what is seen in Turner Syndrome.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Low Posterior Hairline</strong>: Correct statement. A low posterior hairline is another typical physical feature of Noonan Syndrome. This refers to hair growth that extends unusually low on the back of the neck.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Noonan Syndrome presents with distinctive physical features including short stature, webbed neck, and low posterior hairline, but has a normal karyotype, distinguishing it from chromosomal disorders like Turner Syndrome which may present with similar physical characteristics but show chromosomal abnormalities on karyotype analysis.</span></p>",
      "correct_choice_id": 191522,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "OlderNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 45653,
      "choices": [
        {
          "id": 182251,
          "text": "<p><span style=\"font-size:12.0pt;\">Anthrax</span></p>"
        },
        {
          "id": 182252,
          "text": "<p><span style=\"font-size:12.0pt;\">Scrub typhus</span></p>"
        },
        {
          "id": 182253,
          "text": "<p><span style=\"font-size:12.0pt;\">Rocky Mountain spotted fever</span></p>"
        },
        {
          "id": 182254,
          "text": "<p><span style=\"font-size:12.0pt;\">Epidemic Typhus</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Patient came with fever, rash and eschar formation. On examination, mite bite was also present. What is the diagnosis?&nbsp;</span>(FMGE JANUARY 2024)</p>",
      "unique_key": "Q7330719",
      "question_audio": null,
      "question_video": null,
      "map_id": 31148158,
      "difficulty_level": "beginner",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Scrub typhus</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>The key points that support this diagnosis are:</strong></span></p><p>&nbsp;</p><ol><li><span style=\"font-size:12.0pt;\">The presence of <strong>eschar</strong>, which is a common finding in scrub typhus and anthrax.</span></li><li><span style=\"font-size:12.0pt;\">The <strong>mite bite</strong>, which is the biggest clue provided, as scrub typhus is transmitted by the bite of larval mites (chiggers).</span></li><li><span style=\"font-size:12.0pt;\">The explanation that among the rickettsial diseases mentioned in the options (scrub typhus, Rocky Mountain spotted fever, and epidemic typhus), only scrub typhus is transmitted by mites.</span></li></ol><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Scrub typhus is a rickettsial disease caused by the bacteria Orientia tsutsugamushi and transmitted by the bite of larval mites, commonly known as chiggers.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Triad – Eschar; Regional lymphadenopathy and Maculopapular rash</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/27/screenshot-2024-05-27-111649.jpg\" alt=\"\" width=\"500\" height=\"250\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/27/screenshot-2024-05-27-105818.jpg\" alt=\"\" width=\"400\" height=\"289\"></span></p><p>&nbsp;</p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>*Coxiella and&nbsp; Bartonella&nbsp; are now excluded from this family</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Anthrax:</strong> Anthrax is caused by the bacteria Bacillus anthracis and is not transmitted by mite bites. It is a zoonotic disease acquired through contact with infected animals or their products, inhalation of spores, or ingestion of contaminated food.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Rocky Mountain spotted fever:</strong> This is another rickettsial disease, but it is transmitted by ticks, not mites. The presence of a mite bite in the given scenario rules out this option.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Epidemic Typhus:</strong> Caused by Rickettsia prowazekii and transmitted by lice, epidemic typhus presents with a rash but does not typically include eschar formation, nor is it associated with mite bites.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p><span style=\"font-size:10pt;\">&nbsp;</span></p><p><span style=\"font-size:12.0pt;\">Scrub typhus is a rickettsial disease caused by Orientia tsutsugamushi and transmitted by the bite of larval mites (chiggers). The presence of eschar, fever, rash, and a mite bite are key clinical features suggestive of this diagnosis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/27/10.jpg\" alt=\"\" width=\"1000\" height=\"412\"></span></p>",
      "correct_choice_id": 182252,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "FMGE"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 20485,
      "choices": [
        {
          "id": 81902,
          "text": "<p><span style=\"font-size:12pt;\">Prolonged recovery time</span></p>"
        },
        {
          "id": 81903,
          "text": "<p><span style=\"font-size:12pt;\">Not knowing the extent of thermal burns</span></p>"
        },
        {
          "id": 81904,
          "text": "<p><span style=\"font-size:12pt;\">Increased bleeding</span></p>"
        },
        {
          "id": 81905,
          "text": "<p><span style=\"font-size:12pt;\">Increased pain</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A woman is planned for a laparoscopic hysterectomy. She asks the surgeon for any disadvantages of this procedure. What is the disadvantage of laparoscopic over open surgery? (NEET PG 2023)</span></p>",
      "unique_key": "Q2117708",
      "question_audio": null,
      "question_video": null,
      "map_id": 31148157,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. B) Not knowing the extent of thermal burns</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Laparoscopic hysterectomy is a minimally invasive procedure that offers numerous benefits compared to open surgery. However, one significant disadvantage is the difficulty in assessing the extent of thermal burns. Thermal burns can occur due to the use of electrosurgical instruments, and the limited visual field in laparoscopic surgery can make it challenging to identify and evaluate the full extent of these burns. This limitation is crucial because undetected thermal injury can lead to postoperative complications.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. Prolonged recovery time:</strong> Laparoscopic surgery typically results in a shorter recovery time compared to open surgery. The minimally invasive nature of the procedure means less tissue damage and faster healing.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. Increased bleeding:</strong> Laparoscopic surgery generally involves less blood loss than open surgery. The precision of the instruments and the smaller incisions contribute to reduced bleeding.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. Increased pain:</strong> One of the advantages of laparoscopic surgery is less postoperative pain. The smaller incisions and less invasive approach result in decreased pain and discomfort for the patient.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">The disadvantage of laparoscopic over open surgery is not knowing the extent of thermal burns.</span></p>",
      "correct_choice_id": 81903,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "RecentNEETPG",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 54878,
      "choices": [
        {
          "id": 218973,
          "text": "<p><span style=\"font-size:12.0pt;\">Subarachnoid hemorrhage</span></p>"
        },
        {
          "id": 218974,
          "text": "<p><span style=\"font-size:12.0pt;\">Retinal detachment</span></p>"
        },
        {
          "id": 218975,
          "text": "<p><span style=\"font-size:12.0pt;\">Vitreous hemorrhage</span></p>"
        },
        {
          "id": 218976,
          "text": "<p><span style=\"font-size:12.0pt;\">Branched retinal artery occlusion</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">22-year-old patient with high myopia and thick glasses presents with floaters in his eyes. What is the cause of this condition? (INICET MAY 2024)</span></p>",
      "unique_key": "Q6134914",
      "question_audio": null,
      "question_video": null,
      "map_id": 31148155,
      "difficulty_level": "intermediate",
      "subjects_id": [
        8
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Retinal detachment</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Retinal detachment occurs when the sensory retina separates from the underlying retinal pigment epithelium. This separation can be due to a retinal break, known as rhegmatogenous retinal detachment, which is the most common type. In patients with high myopia, there is an increased risk of peripheral retinal degeneration, leading to retinal holes that can progress to retinal detachment. The presence of floaters and flashes is a key symptom indicating retinal detachment.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Subarachnoid hemorrhage:</strong> This condition typically presents with sudden severe headache and neurological symptoms rather than visual symptoms like floaters.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Vitreous hemorrhage:</strong> While this can cause floaters, it is more commonly associated with trauma, diabetic retinopathy, or vascular abnormalities rather than high myopia.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Branched retinal artery occlusion:</strong> This condition usually presents with sudden, painless loss of vision in part of the visual field rather than floaters.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Patients with high myopia are at increased risk for peripheral retinal degeneration and subsequent retinal detachment, presenting with symptoms like floaters and flashes.</span></p>",
      "correct_choice_id": 218974,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6100,
      "choices": [
        {
          "id": 24369,
          "text": "<p><span style=\"font-size:12pt;\">Fetal head 5/5 palpable on abdominal examination</span></p>"
        },
        {
          "id": 24370,
          "text": "<p><span style=\"font-size:12pt;\">Two contractions lasting for 10 seconds in 10 minutes</span></p>"
        },
        {
          "id": 24371,
          "text": "<p><span style=\"font-size:12pt;\">More than 5 cm cervical dilatation with complete effacement</span></p>"
        },
        {
          "id": 24372,
          "text": "<p><span style=\"font-size:12pt;\">Rupture of membranes</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A primigravida presents to the labor room at 40 weeks of gestation with lower abdominal pain. She has been in labor for 3 hours. Which of the following will determine if she is in active labor?</span>(NEET PG 2022)</p>",
      "unique_key": "Q5965505",
      "question_audio": null,
      "question_video": null,
      "map_id": 31148156,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. C) More than 5 cm cervical dilatation with complete effacement</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\"><strong>More than 5 cm cervical dilatation with complete effacement:</strong></span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:12pt;\">According to the World Health Organization (WHO) Labor Care Guide (LCG), active labor begins at more than 5 cm of cervical dilatation.</span></li><li><span style=\"font-size:12pt;\">The older definition of active labor was at 4 cm of cervical dilatation.</span></li><li><span style=\"font-size:12pt;\">The American College of Obstetricians and Gynecologists (ACOG) now defines active labor as beginning at more than 6 cm of cervical dilatation.</span></li><li><span style=\"font-size:12pt;\">Complete effacement indicates that the cervix has thinned out, which is a key indicator of active labor progression.</span></li></ul></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. Fetal head 5/5 palpable on abdominal examination:&nbsp;</strong>This indicates that the fetal head is still high in the pelvis and not yet engaged. It does not determine active labor.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. Two contractions lasting for 10 seconds in 10 minutes:&nbsp;</strong>This frequency and duration of contractions are not sufficient to determine active labor. Active labor typically involves regular, strong contractions lasting 45-60 seconds and occurring every 2-3 minutes.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. Rupture of membranes:&nbsp;</strong>While rupture of membranes can occur during labor, it is not a definitive indicator of active labor. Cervical dilation and effacement are more reliable indicators.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Active labor is determined by more than 5 cm of cervical dilatation with complete effacement, according to the WHO Labor Care Guide.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Ref: Page no 138, DC Dutta’s Textbook of Obstetrics, 8<sup>th</sup> edition</strong></span></p>",
      "correct_choice_id": 24371,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "Factual",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 57112,
      "choices": [
        {
          "id": 227837,
          "text": "<p><span style=\"font-size:12.0pt;\">Hyperglycemia</span></p>"
        },
        {
          "id": 227838,
          "text": "<p><span style=\"font-size:12.0pt;\">Reactive Hypoglycemia</span></p>"
        },
        {
          "id": 227839,
          "text": "<p><span style=\"font-size:12.0pt;\">Hyperlipidemia</span></p>"
        },
        {
          "id": 227840,
          "text": "<p><span style=\"font-size:12.0pt;\">Hyperuricemia</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Giving TPN (total para-enteral nutrition) in a patient in ICU with metabolic syndrome predisposes to: (NEET PG 2024)</span></p>",
      "unique_key": "Q2886094",
      "question_audio": null,
      "question_video": null,
      "map_id": 31148145,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans.&nbsp;A) Hyperglycemia</strong></span></p><p><br><span style=\"font-size:12.0pt;\">Total Parenteral Nutrition (TPN) in a patient with metabolic syndrome predisposes to hyperglycemia. Metabolic syndrome is characterized by insulin resistance, often seen in conditions such as type 2 diabetes, obesity, dyslipidemia, hypertension, and, in some cases, polycystic ovary syndrome (PCOS). Insulin resistance impairs the body’s ability to utilize glucose efficiently. When TPN, which is high in glucose, is administered, the already compromised insulin response leads to elevated blood glucose levels, resulting in hyperglycemia. This is a common complication in patients receiving TPN, especially those with underlying metabolic conditions.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Reactive Hypoglycemia:&nbsp;</strong>Reactive hypoglycemia is a condition where blood glucose levels drop excessively after eating, due to an overproduction of insulin. It is not typically associated with TPN or metabolic syndrome, as TPN administration generally leads to hyperglycemia rather than hypoglycemia due to insulin resistance.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Hyperlipidemia:&nbsp;</strong>While hyperlipidemia is a component of metabolic syndrome, it is not a direct complication specifically associated with TPN. Although TPN can contain lipids, its primary complication related to metabolic syndrome is hyperglycemia due to glucose intolerance.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Hyperuricemia:&nbsp;</strong>Hyperuricemia, characterized by elevated levels of uric acid in the blood, can be associated with metabolic syndrome but is not directly induced by TPN administration. The primary metabolic disturbance from TPN in these patients is related to glucose management rather than uric acid levels.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span><br>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In patients with metabolic syndrome, TPN can exacerbate hyperglycemia due to pre-existing insulin resistance. This underscores the need for careful monitoring of blood glucose levels and management of insulin requirements in these patients.</span></p>",
      "correct_choice_id": 227837,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "RecentNEETPG",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 57891,
      "choices": [
        {
          "id": 230925,
          "text": "<p><span style=\"font-size:12.0pt;\">Primary oocyte arrested in prophase – I</span></p>"
        },
        {
          "id": 230926,
          "text": "<p><span style=\"font-size:12.0pt;\">Secondary oocyte completed in prophase – II</span></p>"
        },
        {
          "id": 230927,
          "text": "<p><span style=\"font-size:12.0pt;\">Primary oocyte arrested in prophase – II</span></p>"
        },
        {
          "id": 230928,
          "text": "<p><span style=\"font-size:12.0pt;\">Secondary oocyte arrested in metaphase – II</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:16px;\">Following ovulation, the oocyte remains halted in which meiotic phase until fertilization? (NEET PG 2024)</span></p>",
      "unique_key": "Q8062545",
      "question_audio": null,
      "question_video": null,
      "map_id": 31148153,
      "difficulty_level": "intermediate",
      "subjects_id": [
        3
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D) Secondary oocyte arrested in metaphase – II</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">After ovulation, the oocyte that is released is the secondary oocyte, which is arrested in metaphase II of meiosis. This arrest continues until fertilization occurs. During fertilization, the entry of sperm triggers the completion of meiosis II, leading to the formation of a mature ovum and the release of the second polar body.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">This arrest in metaphase II is a crucial step in the reproductive cycle, ensuring that the oocyte is ready to complete meiosis only if fertilization occurs, which prevents the wasteful completion of meiosis without fertilization.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/21/screenshot-2024-09-21-111537.jpg\" alt=\"\" width=\"636\" height=\"695\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Primary oocyte arrested in prophase – I:</strong> This phase describes the primary oocyte that is arrested in prophase I during fetal development and remains in this state until puberty. It is not involved in the post-ovulation phase.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Secondary oocyte completed in prophase – II:</strong> This option is incorrect because the secondary oocyte does not complete prophase II. It arrests in metaphase II after ovulation and only completes meiosis II if fertilization occurs.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Primary oocyte arrested in prophase – II:</strong> This is incorrect because the primary oocyte does not arrest in prophase II. It arrests in prophase I, and after puberty, it resumes meiosis to form a secondary oocyte.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The <strong>secondary oocyte</strong> is arrested in <strong>metaphase II</strong> at the time of ovulation and remains in this stage until fertilization occurs, highlighting a critical regulatory checkpoint in the female reproductive cycle.</span></p>",
      "correct_choice_id": 230928,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/57891/Neet_Pg_Aug_2024_Anatomy_Q_16.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [
        "Factual",
        "RecentNEETPG"
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/57891/Neet_Pg_Aug_2024_Anatomy_Q_16.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 45757,
      "choices": [
        {
          "id": 182667,
          "text": "<p><span style=\"font-size:18px;\">Shorter than the incubation period</span></p>"
        },
        {
          "id": 182668,
          "text": "<p><span style=\"font-size:18px;\">Longer than the incubation period</span></p>"
        },
        {
          "id": 182669,
          "text": "<p><span style=\"font-size:18px;\">Equal to the incubation period</span></p>"
        },
        {
          "id": 182670,
          "text": "<p><span style=\"font-size:18px;\">Not related to the incubation period</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\"><strong>In the context of a communicable disease, when the maximal infectivity occurs during the incubation period, what is the relationship between the generation time and the incubation period? </strong><i><strong>[NEET PG 2015]</strong></i></span></p>",
      "unique_key": "Q6807774",
      "question_audio": null,
      "question_video": null,
      "map_id": 31148164,
      "difficulty_level": "intermediate",
      "subjects_id": [
        7
      ],
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.&nbsp;(a) Shorter than the incubation period</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Generation time is defined as \"the interval of time between receipt of infection by a host and maximal infectivity of that host.\"&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">When maximal infectivity occurs during the incubation period (before symptoms appear), the generation time must be shorter than the incubation period, as the incubation period extends from infection until the first appearance of symptoms.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Though generation time is generally roughly equal to incubation period, this specific scenario describes a situation where maximum infectivity precedes symptom onset.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Longer than the incubation period:</strong> This would only be true if maximal infectivity occurred after the appearance of symptoms (after the incubation period ended), but the question specifically states maximal infectivity occurs during the incubation period.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Equal to the incubation period:</strong> While generation time is roughly equal to the incubation period in many diseases, this does not apply when maximal infectivity occurs before the end of the incubation period, as specified in the question.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Not related to the incubation period:</strong> These concepts are clearly related. Generation time and incubation period are related concepts in infectious disease epidemiology, with specific temporal relationships.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Generation time measures the interval from infection to maximal infectivity, while incubation period measures time from infection to symptom onset. Their relationship varies by disease, but when maximal infectivity occurs during the incubation period, generation time must be shorter than incubation period.</span></p>",
      "correct_choice_id": 182667,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "OlderNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 84286,
      "choices": [
        {
          "id": 335720,
          "text": "<p style=\"margin-left:0cm;\"><span style=\"font-size:16px;\">Mifepristone</span></p>"
        },
        {
          "id": 335721,
          "text": "<p style=\"margin-left:0cm;\"><span style=\"font-size:16px;\">Misoprostol</span></p>"
        },
        {
          "id": 335722,
          "text": "<p style=\"margin-left:0cm;\"><span style=\"font-size:16px;\">Dinoprostone</span></p>"
        },
        {
          "id": 335723,
          "text": "<p style=\"margin-left:0cm;\"><span style=\"font-size:16px;\">Methotrexate</span></p>"
        }
      ],
      "text": "<p style=\"margin-left:0cm;\"><span style=\"font-size:16px;\">Mobius syndrome in a fetus may be caused by the maternal intake of which of the following medications? (NEET PG 2016)</span></p>",
      "unique_key": "Q7044266",
      "question_audio": null,
      "question_video": null,
      "map_id": 31148147,
      "difficulty_level": "intermediate",
      "subjects_id": [
        14
      ],
      "solution": "<p style=\"margin-left:0cm;\"><span style=\"font-size:16px;\"><strong>Ans. B) Misoprostol</strong></span></p><p style=\"margin-left:0cm;\">&nbsp;</p><p style=\"margin-left:0cm;\"><span style=\"font-size:16px;\">Misoprostol has been clearly documented as causing Mobius sequency in fetuses when mothers take it during pregnancy. This condition is characterized by facial palsy and limb abnormalities. The teratogenic effect specifically affects cranial nerve development, resulting in the characteristic facial paralysis seen in Mobius syndrome.</span></p><p style=\"margin-left:0cm;\">&nbsp;</p><p style=\"margin-left:0cm;\"><span style=\"font-size:16px;\"><strong>Other Options:</strong></span></p><p style=\"margin-left:0cm;\">&nbsp;</p><p style=\"margin-left:0cm;\"><span style=\"font-size:16px;\"><strong>Option A. Mifepristone</strong>: While mifepristone is used for medical abortion, it has not been associated with Mobius syndrome specifically. It functions primarily as a progesterone receptor antagonist rather than causing cranial nerve developmental defects.</span></p><p style=\"margin-left:0cm;\">&nbsp;</p><p style=\"margin-left:0cm;\"><span style=\"font-size:16px;\"><strong>Option C. Dinoprostone</strong>: Dinoprostone (prostaglandin E2) is not linked to Mobius syndrome. It is commonly used for cervical ripening and labor induction but lacks the specific teratogenic effect on cranial nerve development that would lead to Mobius syndrome.</span></p><p style=\"margin-left:0cm;\">&nbsp;</p><p style=\"margin-left:0cm;\"><span style=\"font-size:16px;\"><strong>Option D. Methotrexate</strong>: Methotrexate is associated with craniosynostosis (clover leaf skull) but not with Mobius syndrome. As a folic acid antagonist, methotrexate affects rapidly dividing cells and can cause various congenital abnormalities, but Mobius syndrome is not among them.</span></p><p style=\"margin-left:0cm;\">&nbsp;</p><p style=\"margin-left:0cm;\"><span style=\"font-size:16px;\"><strong>Educational Objective:</strong></span></p><p style=\"margin-left:0cm;\">&nbsp;</p><p style=\"margin-left:0cm;\"><span style=\"font-size:16px;\">Misoprostol exposure during pregnancy can cause Mobius syndrome (facial palsy and limb abnormalities), making it crucial to avoid during early fetal development.</span></p>",
      "correct_choice_id": 335721,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "OlderNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 56187,
      "choices": [
        {
          "id": 224169,
          "text": "<p><span style=\"font-size:12.0pt;\">ADPKD</span></p>"
        },
        {
          "id": 224170,
          "text": "<p><span style=\"font-size:12.0pt;\">Calcium oxalate stones</span></p>"
        },
        {
          "id": 224171,
          "text": "<p><span style=\"font-size:12.0pt;\">Cystinuria</span></p>"
        },
        {
          "id": 224172,
          "text": "<p><span style=\"font-size:12.0pt;\">Glomerulonephritis</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 26-year-old male presented with colicky pain. Following type of crystals were found on urine examination. What is the likely diagnosis? (NEET PG 2024)</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/06/screenshot-2024-09-06-174323.jpeg\" alt=\"\" width=\"300\" height=\"304\"></span></p>",
      "unique_key": "Q7197163",
      "question_audio": null,
      "question_video": null,
      "map_id": 31148146,
      "difficulty_level": "beginner",
      "subjects_id": [
        1
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans.&nbsp;C) Cystinuria</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The urine examination shows hexagonal crystals, which are characteristic of cystine crystals. These crystals are pathognomonic of cystinuria, a genetic disorder that affects the renal reabsorption of dibasic amino acids, including cystine, ornithine, lysine, and arginine. Cystinuria leads to the formation of cystine stones in the kidneys, bladder, and ureters, often presenting with colicky pain due to stone obstruction.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Cystine crystals appear as flat, hexagonal plates, which is a distinctive feature that helps differentiate them from other types of crystals seen in urine.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. ADPKD (Autosomal Dominant Polycystic Kidney Disease):</strong> This condition involves the development of multiple cysts in the kidneys, leading to kidney enlargement and dysfunction. It does not typically present with hexagonal crystals in the urine; the crystals seen are more commonly calcium oxalate.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Calcium oxalate stones:</strong> These stones are among the most common kidney stones and appear as envelope or dumbbell-shaped crystals, not hexagonal. They are usually related to hyperoxaluria and not cystinuria.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Glomerulonephritis:</strong> This condition involves inflammation of the glomeruli in the kidneys, leading to symptoms like hematuria, proteinuria, and hypertension. It does not present with specific crystals like the hexagonal cystine crystals seen in cystinuria.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Hexagonal cystine crystals in urine are characteristic of cystinuria, a genetic disorder affecting the renal absorption of certain amino acids, leading to recurrent cystine stone formation.</span></p>",
      "correct_choice_id": 224171,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/56187/Neet_Pg_Aug_2024_Biochemistry_Q_25.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [
        "ClinicalVignette",
        "ImageBased",
        "RecentNEETPG"
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/56187/Neet_Pg_Aug_2024_Biochemistry_Q_25.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50695,
      "choices": [
        {
          "id": 202319,
          "text": "<p><span style=\"font-size:12.0pt;\">They are infectious proteins</span></p>"
        },
        {
          "id": 202320,
          "text": "<p><span style=\"font-size:12.0pt;\">They are made up of bacteria and virus</span></p>"
        },
        {
          "id": 202321,
          "text": "<p><span style=\"font-size:12.0pt;\">They have rich nuclear material</span></p>"
        },
        {
          "id": 202322,
          "text": "<p><span style=\"font-size:12.0pt;\">They can be cultured in cell-free media</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following statements about prions is true? (NEET PG 2015)</span></p>",
      "unique_key": "Q2211079",
      "question_audio": null,
      "question_video": null,
      "map_id": 31148162,
      "difficulty_level": "beginner",
      "subjects_id": [
        6
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Correct Answer: A. They are infectious proteins</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation:</strong></span></p><p><br><span style=\"font-size:12.0pt;\">Prions are <strong>infectious proteins</strong> without any nucleic acid. These proteinaceous infectious particles are responsible for transmissible spongiform encephalopathies. Unlike conventional pathogens, prions consist solely of abnormally folded proteins that can induce normal proteins to also misfold, creating a self-propagating infectious agent without genetic material.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option&nbsp;B. They are made up of bacteria and virus</strong> - This is incorrect. Prions are not composed of bacteria or viruses. They are misfolded proteins with no cellular or viral components. Bacteria are complete prokaryotic cells with cell walls and genetic material, while viruses contain nucleic acid (DNA or RNA) surrounded by a protein coat. Prions lack both cellular structures and nucleic acids.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option&nbsp;C. They have rich nuclear material</strong> - This is incorrect. Prions completely lack nucleic acids (DNA or RNA), which distinguishes them from all other infectious agents. They are purely protein in nature with no genetic material whatsoever.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option&nbsp;D. They can be cultured in cell-free media</strong> - This is incorrect. Prions cannot be cultivated on cell-free media because they lack the metabolic machinery for self-replication. Unlike bacteria which can grow on nutrient media, prions require host cellular machinery to propagate. They replicate by converting normal proteins to the pathogenic form.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Prions represent a unique class of infectious agents consisting solely of misfolded proteins without nucleic acids, challenging the central dogma that transmission of biological information requires DNA or RNA.</span></p>",
      "correct_choice_id": 202319,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "OlderNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 51049,
      "choices": [
        {
          "id": 203725,
          "text": "<p><span style=\"font-size:12.0pt;\">It is caused by Burkholderia mallei.</span></p>"
        },
        {
          "id": 203726,
          "text": "<p><span style=\"font-size:12.0pt;\">It is endemic to Southeast Asia.</span></p>"
        },
        {
          "id": 203727,
          "text": "<p><span style=\"font-size:12.0pt;\">It can present similarly to Pulmonary Tuberculosis.</span></p>"
        },
        {
          "id": 203728,
          "text": "<p><span style=\"font-size:12.0pt;\">The bacterium is considered a potential biowarfare agent.</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following statements concerning Melioidosis is incorrect? (NEET PG 2015)</span></p>",
      "unique_key": "Q1794603",
      "question_audio": null,
      "question_video": null,
      "map_id": 31148166,
      "difficulty_level": "intermediate",
      "subjects_id": [
        6
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Correct Answer: A (It is caused by Burkholderia mallei).</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation:</strong></span></p><p><span style=\"font-size:12.0pt;\">Melioidosis is caused by Burkholderia pseudomallei, not Burkholderia mallei. B. pseudomallei is a saprophyte found in soil and water in endemic regions. It causes a disease called melioidosis which has been nicknamed the \"Vietnam time-bomb disease\" due to its ability to remain latent for many years before activating. B. mallei, on the other hand, is a strictly zoonotic pathogen that causes glanders and farcy in horses and other equids.</span></p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. It is endemic to Southeast Asia</strong> - This statement is true. Melioidosis is endemic to Southeast Asia, particularly in Thailand, Vietnam, Malaysia, Singapore and northern Australia. The bacterium B. pseudomallei is found in soil and water in these regions, where environmental conditions favor its survival.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. It can present similarly to Pulmonary Tuberculosis</strong> - This statement is true. One of the clinical presentations of melioidosis is sub-acute pulmonary infection that can range from mild bronchitis to severe tuberculosis-like pneumonia. This tuberculosis-like presentation is one reason why melioidosis is often called \"the great mimicker\" in endemic regions.</span></p><p><span style=\"font-size:12.0pt;\"><strong>Option D. The bacterium is considered a potential biowarfare agent</strong> - This statement is true. B. pseudomallei is classified as a potential agent of biological warfare due to its environmental persistence, relatively low infectious dose when aerosolized, resistance to many common antibiotics, and the serious nature of the disease it causes.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective</strong>:&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Melioidosis is caused by Burkholderia pseudomallei (not B. mallei), can present with a variety of clinical manifestations from acute septicemia to chronic suppurative infections, and requires prolonged antibiotic therapy typically consisting of an intensive phase with ceftazidime or a carbapenem followed by an extended eradication phase with oral antibiotics.</span></p>",
      "correct_choice_id": 203725,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "OlderNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 43906,
      "choices": [
        {
          "id": 175287,
          "text": "<p><span style=\"font-size:12.0pt;\">Trisodium Citrate</span></p>"
        },
        {
          "id": 175288,
          "text": "<p><span style=\"font-size:12.0pt;\">Potassium oxalate</span></p>"
        },
        {
          "id": 175289,
          "text": "<p><span style=\"font-size:12.0pt;\">Sodium fluoride</span></p>"
        },
        {
          "id": 175290,
          "text": "<p><span style=\"font-size:12.0pt;\">EDTA</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A physician wanted to perform plasma glucose estimation using the vacutainer shown in the image. Which of the following is the anticoagulant used for this test?</span> <span style=\"font-size:12.0pt;\">(INICET NOV 2023)</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/13/screenshot-2024-05-13-151112.JPG\" alt=\"\" width=\"200\" height=\"290\"></span></p>",
      "unique_key": "Q2601970",
      "question_audio": null,
      "question_video": null,
      "map_id": 31148168,
      "difficulty_level": "difficult",
      "subjects_id": [
        5
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Potassium oxalate</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Potassium oxalate is commonly used in vacutainers for plasma glucose estimation because it acts as both an anticoagulant and it prevents clotting by binding calcium in the blood. We presume that the examiner by mistake showed the blue topped vacutainer in place of the gray one. However let us review that blue-topped vacutainer contains Trisodium citrate while the gray-topped vacutainer contains Potassium oxalate</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Trisodium Citrate:&nbsp;</strong>Used primarily as an anticoagulant in blood collection tubes for coagulation studies, not suitable for glucose estimation because it does not prevent glycolysis effectively.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Sodium fluoride:&nbsp;</strong>Also a glycolysis inhibitor and commonly used with an anticoagulant (potassium oxalate) in glucose testing..</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. EDTA:&nbsp;</strong>Mainly used as an anticoagulant in hematology tests. While it effectively prevents blood clots, it does not inhibit glycolysis, making it unsuitable for glucose tests.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p><span style=\"font-size:11pt;\"><strong>&nbsp;</strong></span></p><p><span style=\"font-size:12.0pt;\">For accurate plasma glucose estimation, potassium oxalate and enolase is used because it effectively prevents blood clotting and preserves glucose by inhibiting glycolysis respectively.&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Always use a grey-top tube (NaF/KOx) when measuring plasma glucose to prevent post-collection glycolysis and falsely low results.</span></p>",
      "correct_choice_id": 175288,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "ImageBased",
        "INICET",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 54926,
      "choices": [
        {
          "id": 219165,
          "text": "<p><span style=\"font-size:12.0pt;\">Vitamin A</span></p>"
        },
        {
          "id": 219166,
          "text": "<p><span style=\"font-size:12.0pt;\">Vitamin B1</span></p>"
        },
        {
          "id": 219167,
          "text": "<p><span style=\"font-size:12.0pt;\">Vitamin C</span></p>"
        },
        {
          "id": 219168,
          "text": "<p><span style=\"font-size:12.0pt;\">Vitamin B3</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which vitamin deficiency is associated with the dermatological condition shown in the image?</span><span style=\"font-size:11.0pt;\"> (</span><span style=\"font-size:12.0pt;\">FMGE JULY 2024)</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/27/whatsapp-image-2024-08-27-at-53738-pm.jpeg\" alt=\"\" width=\"300\" height=\"384\"></span></p>",
      "unique_key": "Q4702151",
      "question_audio": null,
      "question_video": null,
      "map_id": 31148148,
      "difficulty_level": "beginner",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D) Vitamin B3</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The dermatological condition shown in the image is characterized by a photosensitive rash. This type of rash typically occurs in areas exposed to sunlight, such as the face, neck, and hands. The condition depicted is pellagra, which is caused by a deficiency in Vitamin B3 (niacin). Pellagra is associated with the <strong>\"4 Ds\": diarrhea, dementia, dermatitis, and death</strong>. The dermatitis in pellagra is often photosensitive, meaning it worsens with exposure to sunlight, which explains the rash seen in the image.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Vitamin A:</strong> Deficiency in Vitamin A leads to conditions like night blindness and xerophthalmia (dry eyes), not photosensitive rashes.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Vitamin B1:</strong> Deficiency in Vitamin B1 (thiamine) causes beriberi, which affects the cardiovascular and nervous systems, not the skin.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Vitamin C:</strong> Deficiency in Vitamin C results in scurvy, which is characterized by symptoms like bleeding gums, bruising, and joint pain, but not typically photosensitive rashes.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">A deficiency in Vitamin B3 (niacin) causes pellagra, which presents with a photosensitive rash among other symptoms like diarrhea, dementia, and dermatitis.</span></p>",
      "correct_choice_id": 219168,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "FMGE",
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 14519,
      "choices": [
        {
          "id": 58037,
          "text": "<p><span style=\"font-size:12.0pt;\">Lymphedema</span></p>"
        },
        {
          "id": 58038,
          "text": "<p><span style=\"font-size:12.0pt;\">Lymphangiosarcoma</span></p>"
        },
        {
          "id": 58039,
          "text": "<p><span style=\"font-size:12.0pt;\">Venous thrombosis</span></p>"
        },
        {
          "id": 58040,
          "text": "<p><span style=\"font-size:12.0pt;\">Cellulitis</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Mrs. Johnson, a 54-year-old woman, underwent surgery for breast carcinoma last year. She now presents with painless swelling involving her left arm, which started 2 weeks ago. Upon examination, the affected arm appears swollen and feels heavy, with visible thickening of the skin. There is no warmth, redness, or tenderness. What is the most likely diagnosis?&nbsp;</span><span style=\"font-size:11pt;\">(NEET PG 2021)</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/05/07/ns5.jpg\" alt=\"\" width=\"300\" height=\"300\"></span></p>",
      "unique_key": "Q9365314",
      "question_audio": null,
      "question_video": null,
      "map_id": 31148152,
      "difficulty_level": "beginner",
      "subjects_id": [
        12
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. A. Lymphedema</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">Lymphedema is the most likely diagnosis given the patient's medical history and clinical presentation.</span></li><li><span style=\"font-size:12pt;\">&nbsp;Lymphedema is a common complication of breast cancer surgery, particularly when lymph nodes are removed or damaged during the procedure, leading to poor drainage of lymphatic fluid from the affected arm.</span></li><li><span style=\"font-size:12pt;\">The swelling in lymphedema is usually painless, and the skin may feel tight or heavy.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. Lymphangiosarcoma:&nbsp; </strong>Lymphangiosarcoma is a rare type of cancer that can develop in the lymphatic vessels, often years after radiation therapy or surgery for breast cancer. Symptoms may include pain, swelling, and skin changes in the affected area. However, it is a very uncommon complication compared to lymphedema.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. Venous thrombosis:&nbsp;</strong>Venous thrombosis is a blood clot that develops in a vein, usually presenting with symptoms like swelling, pain, and warmth in the affected area. In this case, the swelling is painless and is more indicative of lymphatic fluid accumulation rather than a venous thrombosis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. Cellulitis:&nbsp;</strong>Cellulitis is a bacterial infection of the skin and soft tissues, presenting with symptoms such as redness, swelling, pain, and warmth. The absence of warmth, redness, and tenderness in the patient's presentation makes cellulitis an unlikely diagnosis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">Lymphedema is a common postoperative complication of breast cancer surgery due to the removal or damage of lymph nodes, leading to poor lymphatic drainage.</span></li><li><span style=\"font-size:12pt;\">&nbsp;It presents as painless swelling, heaviness, and skin thickening in the affected limb.</span></li></ul>",
      "correct_choice_id": 58037,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "ImageBased",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 45872,
      "choices": [
        {
          "id": 183115,
          "text": "<p><span style=\"font-size:12.0pt;\">Glutamine</span></p>"
        },
        {
          "id": 183116,
          "text": "<p><span style=\"font-size:12.0pt;\">Glycine</span></p>"
        },
        {
          "id": 183117,
          "text": "<p><span style=\"font-size:12.0pt;\">Glutamate</span></p>"
        },
        {
          "id": 183118,
          "text": "<p><span style=\"font-size:12.0pt;\">Valine</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Heme is derived from which of the following amino acids?&nbsp;</span><span style=\"font-size:14px;\">(FMGE JANUARY 2024)</span></p>",
      "unique_key": "Q2176652",
      "question_audio": null,
      "question_video": null,
      "map_id": 31148159,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Glycine</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Heme is derived from glycine, which is one of the simplest amino acids. Despite its simplicity, glycine is a precursor to several important biological compounds. In the heme biosynthesis pathway, glycine combines with succinyl-CoA to form δ-aminolevulinic acid, which is the first step in the synthesis of heme. Heme is a critical component of hemoglobin, myoglobin, and various cytochromes, playing a vital role in oxygen transport and cellular respiration.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Glutamine:</strong> Glutamine is involved in various metabolic processes, including the synthesis of nucleotides and amino sugars, but it does not contribute directly to heme biosynthesis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Glutamate:</strong> Glutamate is a key neurotransmitter and is involved in the synthesis of glutathione and other amino acids but not directly in heme formation.</span></p><p style=\"margin-left:48px;\">&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Valine:</strong> Valine is a branched-chain amino acid important in protein synthesis and energy metabolism but not in the biosynthesis of heme.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Products of amino acids -</strong></span></p><ul><li><span style=\"font-size:12.0pt;\">Tryptophan – Niacin, serotonin, melatonin</span></li><li><span style=\"font-size:12.0pt;\">Tyrosine - Melanin, catecholamine, thyroxin</span></li><li><span style=\"font-size:12.0pt;\">Histidine – Histamine, Carnosine, Anserine</span></li><li><span style=\"font-size:12.0pt;\">Glycine- Creatine, Glutathione, <strong>Haem</strong>, Porphyrin, Glyoxylate, Choline, Betaine, serine, Sarcosine</span></li></ul><p style=\"margin-left:48px;\"><span style=\"font-size:12.0pt;\">Glutathione – tripeptide →&nbsp; Glutamate, Cysteine &amp; Glycine</span></p><p style=\"margin-left:48px;\"><span style=\"font-size:12.0pt;\">Creatine- made from 3 AA → Arginine, Methionine &amp; Glycine</span></p><ul><li><span style=\"font-size:12.0pt;\">Serine → Glycine, Selenocysteine, Phosphatidyl serine, Sphingosine (Serine + Palmitoyl CoA)</span></li><li><span style=\"font-size:12.0pt;\">Arginine - NO, Creatine, Urea &amp; Ornithine</span></li></ul>",
      "correct_choice_id": 183116,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "FMGE"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    }
  ]
}